• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis.种族独立估计肾小球滤过率与事件性心力衰竭风险再分类:美国国立心肺血液研究所队列分析。
J Card Fail. 2024 Jan;30(1):14-22. doi: 10.1016/j.cardfail.2023.07.009. Epub 2023 Aug 4.
2
Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.肌酐与胱抑素 C 估算的肾小球滤过率个体内差异与心力衰竭事件的关系。
Am J Kidney Dis. 2022 Dec;80(6):762-772.e1. doi: 10.1053/j.ajkd.2022.05.011. Epub 2022 Jul 9.
3
Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.基于种族无关方程估算肾小球滤过率与黑种人与非黑种人肾衰竭和死亡率的关联。
JAMA. 2022 Jun 21;327(23):2306-2316. doi: 10.1001/jama.2022.8801.
4
Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.胱抑素 C 与肥胖相关的肾脏和心血管结局的关联修饰。
Am J Kidney Dis. 2024 Apr;83(4):489-496.e1. doi: 10.1053/j.ajkd.2023.08.021. Epub 2023 Oct 20.
5
CKD Prevalence and Incidence in Older Adults Using Estimated GFR With Different Filtration Markers: The Atherosclerosis Risk in Communities Study.使用不同滤过标志物估算肾小球滤过率时老年人慢性肾脏病的患病率和发病率:社区动脉粥样硬化风险研究
Kidney Med. 2024 Aug 14;6(10):100893. doi: 10.1016/j.xkme.2024.100893. eCollection 2024 Oct.
6
Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.白蛋白尿和估计肾小球滤过率作为中年和老年痴呆风险因素:来自 ARIC 研究的发现。
Am J Kidney Dis. 2020 Dec;76(6):775-783. doi: 10.1053/j.ajkd.2020.03.015. Epub 2020 May 16.
7
Prediction of cardiovascular events and all-cause mortality using race and race-free estimated glomerular filtration rate in African Americans: the Jackson Heart Study.利用种族和无种族估计肾小球滤过率预测非裔美国人的心血管事件和全因死亡率:杰克逊心脏研究
Front Med (Lausanne). 2024 Oct 31;11:1432965. doi: 10.3389/fmed.2024.1432965. eCollection 2024.
8
Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China.基于血清肌酐和胱抑素 C 的估算肾小球滤过率与新发糖尿病的关联:中国一项全国性队列研究。
Acta Diabetol. 2021 Sep;58(9):1269-1276. doi: 10.1007/s00592-021-01719-5. Epub 2021 Apr 28.
9
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.2021 年 Race-Free CKD-EPI 基于肌酐和胱抑素 C 的估算肾小球滤过率方程在肾移植受者中的表现。
Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16.
10
Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.社区中的肾功能与心源性猝死:社区动脉粥样硬化风险(ARIC)研究
Am Heart J. 2016 Oct;180:46-53. doi: 10.1016/j.ahj.2016.07.004. Epub 2016 Jul 14.

引用本文的文献

1
Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes.克服在使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂对有和没有2型糖尿病的人群进行心肾保护方面的差异。
J Clin Endocrinol Metab. 2025 Aug 7;110(9):e2852-e2863. doi: 10.1210/clinem/dgaf301.

本文引用的文献

1
Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.肌酐与胱抑素 C 估算的肾小球滤过率个体内差异与心力衰竭事件的关系。
Am J Kidney Dis. 2022 Dec;80(6):762-772.e1. doi: 10.1053/j.ajkd.2022.05.011. Epub 2022 Jul 9.
2
Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.无需肾功能估计种族系数的心力衰竭患者使用SGLT2抑制剂的资格。
J Am Coll Cardiol. 2021 Oct 19;78(16):1669-1670. doi: 10.1016/j.jacc.2021.08.025.
3
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.一种统一的肾小球滤过率估计方法:NKF-ASN 工作组关于重新评估种族在诊断肾脏疾病中的纳入的建议。
Am J Kidney Dis. 2022 Feb;79(2):268-288.e1. doi: 10.1053/j.ajkd.2021.08.003. Epub 2021 Sep 23.
4
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
5
Estimated glomerular filtration rate equations in people of self-reported black ethnicity in the United Kingdom: Inappropriate adjustment for ethnicity may lead to reduced access to care.英国自我报告为黑人种族人群的肾小球滤过率估计方程:对种族的不当调整可能会导致获得护理的机会减少。
PLoS One. 2021 Aug 12;16(8):e0255869. doi: 10.1371/journal.pone.0255869. eCollection 2021.
6
Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial.肥胖与射血分数降低的心力衰竭有指导的医学治疗中连续 NT-proBNP 水平:来自 GUIDE-IT 试验的见解。
J Am Heart Assoc. 2021 Apr 6;10(7):e018689. doi: 10.1161/JAHA.120.018689. Epub 2021 Mar 23.
7
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2020年年报:美国肾脏疾病流行病学》
Am J Kidney Dis. 2021 Apr;77(4 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2021.01.002.
8
Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.隐匿于众目睽睽之下——重新审视临床算法中种族校正的应用
N Engl J Med. 2020 Aug 27;383(9):874-882. doi: 10.1056/NEJMms2004740. Epub 2020 Jun 17.
9
Kidney Disease Biomarkers Improve Heart Failure Risk Prediction in the General Population.肾脏病生物标志物可改善一般人群心力衰竭风险预测。
Circ Heart Fail. 2020 Aug;13(8):e006904. doi: 10.1161/CIRCHEARTFAILURE.120.006904. Epub 2020 Aug 6.
10
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?慢性肾脏病中的动脉粥样硬化:更多、更少,还是仅仅不同?
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1938-1966. doi: 10.1161/ATVBAHA.119.312705. Epub 2019 Aug 15.

种族独立估计肾小球滤过率与事件性心力衰竭风险再分类:美国国立心肺血液研究所队列分析。

Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis.

机构信息

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.

Cardiovascular Division, University of Minnesota, Minneapolis, MN.

出版信息

J Card Fail. 2024 Jan;30(1):14-22. doi: 10.1016/j.cardfail.2023.07.009. Epub 2023 Aug 4.

DOI:10.1016/j.cardfail.2023.07.009
PMID:37543186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10838360/
Abstract

BACKGROUND

This study compared the predictive value of the race-independent creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR) and the race-dependent creatinine-based eGFR (eGFR) for incident heart failure (HF).

METHODS

This study combined the participant-level data from ARIC (Atherosclerosis Risk in Communities) (visit 4) and MESA (Multi-Ethnic Study of Atherosclerosis) (visit 1) to calculate eGFR and eGFR. The primary outcome of the study was adjudicated incident HF over a follow-up period of 10 years. Multivariable Cox models were used to assess the risk of incident HF with the quartiles of eGFR and eGFR.

RESULTS

Among 15,615 individuals (median age: 62 [57-68] years; 55.0% females; 23.9% Black), the median eGFR and eGFR were 91.4 (79.4, 102.0) mL/min/1.73m and 84.7 (72.0, 94.7) mL/min/1.73m, respectively. Compared with the fourth quartile of eGFR, the hazard ratio for incident HF was 1.02 (95% CI:0.80-1.30) in the third quartile, 1.02 (95% CI:0.80-1.30) in the second quartile, and 1.47 (95% CI:1.16-1.86) in the first quartile. Compared with the 4th quartile of the eGFR the risk of incident HF was similar in the 3rd (HR:0.90 [95% CI:0.73-1.12]), 2nd (HR: 0.96 [95% CI:0.77-1.20]), and 1st (HR:1.15 [95% CI:0.93-1.44]) quartiles. C-statistics were similar for the multivariable-adjusted Cox models for incident HF using eGFR (0.80 [0.79-0.81]) and eGFR (0.80 [0.79-0.82]).

CONCLUSION

The eGFR and eGFR had comparable predictive values for incident HF.

摘要

背景

本研究比较了种族独立的基于肌酐和胱抑素 C 的估算肾小球滤过率(eGFR)与种族依赖的基于肌酐的 eGFR(eGFR)对心力衰竭(HF)的预测价值。

方法

本研究将 ARIC(社区动脉粥样硬化风险)(第 4 次访视)和 MESA(多民族动脉粥样硬化研究)(第 1 次访视)的参与者水平数据合并,以计算 eGFR 和 eGFR。研究的主要结局是在 10 年的随访期间,经裁定的 HF 发生率。使用多变量 Cox 模型评估 eGFR 和 eGFR 四分位数与 HF 发生率的风险。

结果

在 15615 名个体中(中位年龄:62 [57-68]岁;55.0%为女性;23.9%为黑人),中位 eGFR 和 eGFR 分别为 91.4(79.4,102.0)mL/min/1.73m 和 84.7(72.0,94.7)mL/min/1.73m。与 eGFR 的第 4 四分位相比,第 3 四分位的 HF 发生率的危险比为 1.02(95%CI:0.80-1.30),第 2 四分位为 1.02(95%CI:0.80-1.30),第 1 四分位为 1.47(95%CI:1.16-1.86)。与 eGFR 的第 4 四分位相比,HF 发生率在第 3 (HR:0.90 [95%CI:0.73-1.12])、第 2 (HR:0.96 [95%CI:0.77-1.20])和第 1 (HR:1.15 [95%CI:0.93-1.44])四分位相似。使用 eGFR(0.80 [0.79-0.81])和 eGFR(0.80 [0.79-0.82])进行的多变量调整 Cox 模型对 HF 的预测值相似。

结论

eGFR 和 eGFR 对 HF 的预测价值相当。